Differential Diagnosis in Neuroimaging: Brain and Meninges 1st Edition

Differential Diagnosis in Neuroimaging: Brain and Meninges 1st Edition

Authored by renowned neuro-radiologist Steven P. Meyers, Differential Diagnosis in Neuroimaging: Brain and Meninges is a stellar guide for identifying and diagnosing brain pathologies based on location and neuroimaging results. The succinct text reflects more than 25 years of hands-on experience gleaned from advanced training and educating residents and fellows in radiology, neurosurgery, and neurology. The high-quality MRI, CT, PET, PET/CT, conventional angiography, and X-ray images have been collected over Dr. Meyers’s lengthy career, presenting an unsurpassed visual learning tool.

The distinctive ‘three-column table plus images’ format is easy to incorporate into clinical practice, setting this book apart from larger, disease-oriented radiologic tomes. The layout enables readers to quickly recognize and compare abnormalities based on high-resolution images.

Key Highlights

  • Tabular columns organized by anatomical abnormality include brain imaging findings and a summary of key clinical data that correlates to the images
  • Comprehensive imaging of the brain, ventricles, meninges, and neurovascular system in both children and adults, including congenital/developmental anomalies and acquired disease
  • More than 1,900 figures illustrate the radiological appearance of intracranial lesions, masses, neurodegenerative disorders, ischemia and infarction, and more

This visually rich resource is a must-have diagnostic tool for radiologists, neurosurgeons, and neurologists, and residents and fellows. The highly practical format makes it ideal for daily rounds, as well as a robust study guide for physicians preparing for board exams.

DOWNLOAD THIS MEDICAL BOOK 

Detection Systems in Lung Cancer and Imaging (Volume 1)

Detection Systems in Lung Cancer and Imaging (Volume 1)

This book focuses on major trends and challenges in the detection of lung cancer, presenting work aimed at identifying new techniques and their use in biomedical analysis. Volume 1 examines the main applications of computer-aided diagnosis to lung cancer. It is ideal for academics, industry professionals and advanced students.

DOWNLOAD THIS MEDICAL BOOK 

MRCOG Part 2: 550 MCQs, EMQs and SAQs 1st by Wuntakal, Rekha, M.D. (2012)

MRCOG Part 2: 550 MCQs, EMQs and SAQs 1st by Wuntakal, Rekha, M.D. (2012) 

MRCOG PART 2: 550 MCQs, EMQs and SAQs offers the most up-to-date and comprehensive coverage of practice questions for trainees preparing for the MRCOG Part 2 written exam. Presented in a clear layout, chapters are mapped to the syllabus to deliver structured revision in all the key topics. Featuring a wealth of practice questions and fully descriptive answers, this book provides the essential revision tool to maximise chances of exam success.

DOWNLOAD THIS MEDICAL BOOK 

Addiction Psychiatric Medicine: A Comprehensive Board Review 1st Edition

Addiction Psychiatric Medicine: A Comprehensive Board Review 1st Edition

Easy to read and use, Addiction Psychiatric Medicine: A Comprehensive Board Review provides a systematic and comprehensive review of all diseases and disorders frequently tested on addiction psychiatry and addiction medicine board examinations. This high-yield manual is divided into two sections: the first section contains short chapters covering important topics in addiction medicine and psychiatry, including alcohol, sedatives, opioids, tobacco, cannabis, and stimulants; the second section divides questions into three 50-question blocks to resemble the board exam format. This learning tool is essential for exam study in addiction psychiatry or addiction medicine and an excellent resource for interacting with patients with substance abuse disorders.

  • Includes close to 300 multiple choice questions and detailed answer explanations
  • Presents information on clinical concepts, etiologies of diseases, treatments, and preventive measures in a format that’s easy to remember and apply, with tables and clinical points. 
  • Includes commonly missed concepts on exams for addiction psychiatry and addiction medicine to help users achieve optimal sores.
  • Offers quick access to high-yield content critical for success on board exams, clinical clerkships, and medical practice. 
  • Enhanced eBook version included with purchase. Your enhanced eBook allows you to access the question bank, plus all of the text, figures, and references from the book on a variety of devices.

DOWNLOAD THIS MEDICAL BOOK 

DeVita, Hellman, and Rosenberg’s Cancer Principles & Practice of Oncology Review Fifth Edition

DeVita, Hellman, and Rosenberg’s Cancer Principles & Practice of Oncology Review Fifth Edition

Based on DeVita, Hellman, and Rosenberg’s Cancer: Principles and Practice of Oncology, Eleventh Edition, this comprehensive review book covers the entire specialty of oncology, including new or expanded coverage of molecular biology; epidemiology and etiology; screen and prevention; genetics; clinical trials; and immunotherapy. Inside, readers will discover hundreds of multiple-choice and case-based questions, along with detailed answers and explanations to help explain the how and why behind each correct response. The ideal way to maximize exam scores for today’s student and residents!

Learning and review features include:

  • Hundreds of multiple-choice and case-based questions to build comprehension and improve retention.
  • All topics cross-referenced to the latest edition of DeVita, Hellman, and Rosenberg’s Cancer: Principles & Practice of Oncology, Eleventh Edition.
  • Material on all aspects of oncology, including medical, radiation and surgical oncology, as well as hematology/oncology issues

Enrich Your eBook Reading Experience

  • such as computer, tablet, or smartphone.
  • powering your content with natural language text-to-speech.

DOWNLOAD THIS MEDICAL BOOK 

Progress in Medicinal Chemistry (ISSN Book 46) 1st Edition

Progress in Medicinal Chemistry (ISSN Book 46) 1st Edition

Appropriate selection of biochemical targets is one of the most important drivers of cost effectiveness in the discovery of new medicines. Despite the many advances in genetics, genomics and systems biology, ‘validation’ of a target is not achieved until therapeutic efficacy is demonstrated by a drug candidate. Volume 46 of this series reviews the medicinal chemistry aimed at six diverse targets from which important new medicines are emerging: * HIV integrase (discovery of the first-in-class inhibitor drug raltegravir)* 11-beta-Hydroxysteroid dehydrogenase (new approach to glucocorticoid regulation)* Nicotinic a7 choline receptor (agonists and positive allosteric modulators). * Bradykinin receptor (new approach to pain therapy)* Histone deacetylase (new drugs for cancer)* 5-HT2c receptor modulators (various CNS indications)

*Presents the latest research in the field of drug discovery *Publishes on an annual basis to bring you the most innovative updates in medicinal chemistry *Available as an online resource via ScienceDirect

DOWNLOAD THIS MEDICAL BOOK 

Clinical Neuroimmunology: Multiple Sclerosis and Related Disorders (Current Clinical Neurology) 2nd ed. 2020 Edition

Clinical Neuroimmunology: Multiple Sclerosis and Related Disorders (Current Clinical Neurology) 2nd ed. 2020 Edition

This comprehensive, up-to-date book is designed to make recent developments in neuroimmunology accessible to medical professionals in the field. The field of neuroimmunology is complex and rapidly evolving, especially with the current improvements in targeted biologic therapies. This resource concisely offers clear explanations of these scientific and clinical advancements.

Divided into five parts, the book begins with an in-depth introduction to neuroimmunology and the principles of immunotherapy. Section two consists of eight chapters devoted to multiple sclerosis, including discussions on the clinical features of the disease as well as symptom management and diagnosis. Subsequent chapters then dive into other central nervous system inflammatory disorders such as neuromyelitis optica, autoimmune encephalopathies, and immunological aspects of cancer. Following this are two chapters that examine distinct aspects of autoimmune disorders of the peripheral nervous system.Finally, the book closes with a review on the neurologic manifestations, diagnostic approaches and treatments of the various systemic rheumatic diseases.

Following its successful predecessor edition, Clinical Neuroimmunology: Multiple Sclerosis and Related Disorders, Second Edition is positioned to be an invaluable asset to neurologists, residents and fellows, internists, and general practitioners who treat patients with neurologic disorders and other systemic autoimmune diseases.

DOWNLOAD THIS MEDICAL BOOK 

The Art, Science and Technology of Pharmaceutical Compounding 5th Edition

The Art, Science and Technology of Pharmaceutical Compounding 5th Edition

Compounding has always been part of pharmacy practice. Today, the need for compounding is growing, with the prevalence of drug shortages, outsourcing of compounding services by hospitals, and patients’ need for individualized preparations. Compounding pharmacies now have the opportunity to obtain accreditation. The Art, Science, and Technology of Pharmaceutical Compounding presents in a logical and progressive format all the information that pharmacists and student pharmacists need to understand the purpose and processes of compounding. Author Loyd V. Allen Jr., the preeminent expert, covers basic guidelines, economic and technical factors that compounding pharmacists must consider, and all aspects of good manufacturing practices for compounded medications. In this fifth edition, all chapters have been updated and several significantly revised—particularly “Compounding with Hazardous Drugs”—and three new chapters have been added: “Pharmaceutical Compounding Errors,” “Foams,” and “Compounding with Special Ingredients.” Information on the new law affecting compounding, the Drug Quality and Security Act, is incorporated throughout the book. Chapter 13 now includes information on compounding “films.”

KEY FEATURES:

  • The initial chapters describe the requisite facilities and equipment, record keeping, calculations, and quality control.
  • Three new chapters: “Pharmaceutical Compounding Errors,” “Foams,” and “Compounding with Special Ingredients.”
  • Fifteen chapters are devoted to the compounding of each dosage form in turn, from powders and granules to injectables.
  • Additional chapters cover veterinary compounding, compounding for special populations, compounding for specific procedures, compounding for clinical studies, compounding cosmetics, compounding with hazardous drugs, and compounding in the event of a natural disaster or terrorist attack.
  • Nine appendices provide essential information on the compounding process and examples of standard operating procedures.
  • The necessary ingredients and steps are listed for compounding more than 200 sample formulations, including bases, vehicles, and ingredient-specific preparations.
  • Updated throughout, including information on the new Drug Quality and Security Act.

DOWNLOAD THIS MEDICAL BOOK 

Hepatitis and Liver Cancer: A National Strategy for Prevention and Control of Hepatitis B and C Illustrated Edition

Hepatitis and Liver Cancer: A National Strategy for Prevention and Control of Hepatitis B and C Illustrated Edition

The global epidemic of hepatitis B and C is a serious public health problem. Hepatitis B and C are the major causes of chronic liver disease and liver cancer in the world. In the next 10 years, 150,000 people in the United States will die from liver disease or liver cancer associated with chronic hepatitis B virus (HBV) or hepatitis C virus (HCV) infections. Today, between 800,000 and 1.4 million people in the United States have chronic hepatitis B and between 2.7 and 3.9 million have chronic hepatitis C. People most at risk for hepatitis B and C often are the least likely to have access to medical services. Reducing the rates of illness and death associated with these diseases will require greater awareness and knowledge among health care workers, improved identification of at-risk people, and improved access to medical care.

Hepatitis B is a vaccine-preventable disease. Although federal public health officials recommend that all newborns, children, and at-risk adults receive the vaccine, about 46,000 new acute cases of the HBV infection emerge each year, including 1,000 in infants who acquire the infection during birth from their HBV-positive mothers. Unfortunately, there is no vaccine for hepatitis C, which is transmitted by direct exposure to infectious blood.

Hepatitis and Liver Cancer identifies missed opportunities related to the prevention and control of HBV and HCV infections. The book presents ways to reduce the numbers of new HBV and HCV infections and the morbidity and mortality related to chronic viral hepatitis. It identifies priorities for research, policy, and action geared toward federal, state, and local public health officials, stakeholder, and advocacy groups and professional organizations.

DOWNLOAD THIS MEDICAL BOOK 

1 6 7 8 9 10 962